Last week the Food and Drug Administration (FDA) advisory panel recommended that Avandia – a popular diabetes drug linked to a higher risk of heart attack – contain either stronger warning labels or restrict its use.
Avandia is developed and manufactured by GlaxoSmithKline.
In addition to a well-documented increased risk of heart attack, Avandia has been shown to lead to other health complications such as:
- Congestive heart failure
- Liver damage
- Swelling of arms and legs
In the wake of last week’s recommendation for stronger warning labels, the FDA has put a hold on the long-term TIDE study, which compared Avandia with a similar diabetes drug, Actos. Critics have long questioned the ethics of using diabetic patients as “human guinea pigs” to assess the level of risk associated with taking Avandia.
As Albuquerque personal injury attorneys concerned about dangerous drugs, not only do we support stopping the clinical trials of Avandia which continue to put more consumers at risk, but believe this dangerous drug must be taken off the market before more people suffer deaths ad serious injuries as the result of Avandia.